OBJECTIVES: This project was developed to identify ways to support hospital-based improvements for the identification and management of osteoporosis following treatment of a fragility fracture. DESIGN: This is a retrospective review of medical records of sets of consecutive patients who were admitted for surgical treatment of fragility fracture following introduction of several versions of admission and discharge care pathways. Effectiveness of the admission pathway was defined as % subjects with measurement of serum 25- hydroxyvitamin D (25(OH)D) during hospitalization; effectiveness of the discharge pathway was defined as % subjects with documentation of instructions for calcium and/or vitamin D supplementation. SETTING: This study reviewed medical records of patients admitted to hospital for surgical treatment of a fragility fracture. PARTICIPANTS: Medical records were evaluated for 98 patients older than 50-years who were admitted with a fragility fracture of the hip or femur. MEASUREMENTS: Medical records were reviewed for the % subjects with documentation of an in-hospital order for serum 25(OH)D and with documentation of instructions to patients upon discharge concerning calcium and vitamin D intake. Median value of serum 25(OH)D was calculated. RESULTS: In accordance with the admission pathway, serum 25(OH)D was measured in 37% (36/98). The median 25(OH)D level was 19.5 ng/mL; 78% were vitamin D insufficient [serum 25(OH)D < or = 32 ng/mL] and 58% were vitamin D deficient [serum 25(OH)D < or = 20 ng/mL]. In accordance with the discharge pathway, 74% (71/96) were discharged on calcium and/or vitamin D. CONCLUSION: The high prevalence of vitamin D insufficiency (78%) observed in this study affirms the importance of incorporating vitamin D supplementation in hospital-based fracture care pathways. The discharge pathway was more effective than the newer admission pathway, a finding attributable to effects of familiarity, retraining, and introduction of computer-prompts. These evolving pathways represent a much-needed paradigm shift in the care of fragility fracture patients.
OBJECTIVES: This project was developed to identify ways to support hospital-based improvements for the identification and management of osteoporosis following treatment of a fragility fracture. DESIGN: This is a retrospective review of medical records of sets of consecutive patients who were admitted for surgical treatment of fragility fracture following introduction of several versions of admission and discharge care pathways. Effectiveness of the admission pathway was defined as % subjects with measurement of serum 25- hydroxyvitamin D (25(OH)D) during hospitalization; effectiveness of the discharge pathway was defined as % subjects with documentation of instructions for calcium and/or vitamin D supplementation. SETTING: This study reviewed medical records of patients admitted to hospital for surgical treatment of a fragility fracture. PARTICIPANTS: Medical records were evaluated for 98 patients older than 50-years who were admitted with a fragility fracture of the hip or femur. MEASUREMENTS: Medical records were reviewed for the % subjects with documentation of an in-hospital order for serum 25(OH)D and with documentation of instructions to patients upon discharge concerning calcium and vitamin D intake. Median value of serum 25(OH)D was calculated. RESULTS: In accordance with the admission pathway, serum 25(OH)D was measured in 37% (36/98). The median 25(OH)D level was 19.5 ng/mL; 78% were vitamin D insufficient [serum 25(OH)D < or = 32 ng/mL] and 58% were vitamin D deficient [serum 25(OH)D < or = 20 ng/mL]. In accordance with the discharge pathway, 74% (71/96) were discharged on calcium and/or vitamin D. CONCLUSION: The high prevalence of vitamin Dinsufficiency (78%) observed in this study affirms the importance of incorporating vitamin D supplementation in hospital-based fracture care pathways. The discharge pathway was more effective than the newer admission pathway, a finding attributable to effects of familiarity, retraining, and introduction of computer-prompts. These evolving pathways represent a much-needed paradigm shift in the care of fragility fracturepatients.
Authors: Heike A Bischoff-Ferrari; Thomas Dietrich; E John Orav; Frank B Hu; Yuqing Zhang; Elisabeth W Karlson; Bess Dawson-Hughes Journal: Am J Clin Nutr Date: 2004-09 Impact factor: 7.045
Authors: P Lips; J C Netelenbos; M J Jongen; F C van Ginkel; A L Althuis; C L van Schaik; W J van der Vijgh; J P Vermeiden; C van der Meer Journal: Metab Bone Dis Relat Res Date: 1982
Authors: Heike A Bischoff-Ferrari; Bess Dawson-Hughes; Walter C Willett; Hannes B Staehelin; Marlet G Bazemore; Robert Y Zee; John B Wong Journal: JAMA Date: 2004-04-28 Impact factor: 56.272
Authors: Ethel S Siris; John P Bilezikian; Mishaela R Rubin; Dennis M Black; Richard S Bockman; Henry G Bone; Marc C Hochberg; Michael R McClung; Thomas J Schnitzer Journal: J Clin Endocrinol Metab Date: 2003-08 Impact factor: 5.958
Authors: Susan E Andrade; Sumit R Majumdar; K Arnold Chan; Diana S M Buist; Alan S Go; Michael Goodman; David H Smith; Richard Platt; Jerry H Gurwitz Journal: Arch Intern Med Date: 2003-09-22
Authors: Helen C Roberts; Ruth M Pickering; Elizabeth Onslow; Mike Clancy; Jackie Powell; Alison Roberts; Kerry Hughes; Diane Coulson; Jane Bray Journal: Age Ageing Date: 2004-03 Impact factor: 10.668
Authors: Paulette D Chandler; Edward L Giovannucci; Michelle A Williams; Meryl S LeBoff; David W Bates; LeRoi S Hicks Journal: Am J Pharm Benefits Date: 2014
Authors: Julie Glowacki; Mitchel B Harris; Josef Simon; John Wright; Nikheel S Kolatkar; Thomas S Thornhill; Meryl S Leboff Journal: Int J Endocrinol Date: 2010 Impact factor: 3.257